移动健康在心房颤动患者健康管理中的应用进展

doi:10.3761/j.issn.0254-1769.2022.11.006

摘要/Abstract

摘要：

心房颤动是导致脑卒中、心力衰竭、痴呆、猝死等发生的主要原因之一,具有较高的致残率和致死率。移动健康在心房颤动患者健康管理领域效果显著。该文介绍了移动健康的定义、形式及其在心房颤动患者健康管理中的应用,包括心房颤动筛查、风险评估、自我监测、健康教育、用药管理、危险因素干预6个方面,并对应用中存在的问题进行总结并提出建议,以期为国内开发专业化、高质量的心房颤动患者健康管理移动健康技术提供借鉴和参考。

关键词: 移动健康, 心房颤动, 护理, 综述

Abstract:

Atrial fibrillation is one of the main causes of stroke,heart failure,dementia and sudden death worldwide,with high rate of disability and mortality. Mobile health has a significant effect on the health management of patients with atrial fibrillation. This paper introduces the definition,form and application of mobile health in the health management of patients with atrial fibrillation,including atrial fibrillation screening,risk assessment,self-monitoring,health education,medication management and risk factor intervention. It also summarizes the existing problems and puts forward proposals,so as to provide references for the development of professional and high-quality mobile health technology for the health management of patients with atrial fibrillation in China.

Key words: Mobile Health, Atrial Fibrillation, Nursing Care, Review

连晓倩, 张鑫, 许林琪, 于天卓, 于天悦, 李峰. 移动健康在心房颤动患者健康管理中的应用进展[J]. 中华护理杂志, 2022, 57(11): 1318-1323.

LIAN Xiaoqian, ZHANG Xin, XU Linqi, YU Tianzhuo, YU Tianyue, LI Feng. Research progress of mobile health in the health management of patients with atrial fibrillation[J]. Chinese Journal of Nursing, 2022, 57(11): 1318-1323.

参考文献 47

[1]	Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS):the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2021, 42(5):373-498. DOI PMID
[2]	Du X, Guo LZ, Xia SJ, et al. Atrial fibrillation prevalence,awareness and management in a nationwide survey of adults in China[J]. Heart, 2021, 107(7):535-541. DOI URL
[3]	January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society[J]. J Am Coll Cardiol, 2019, 74(1):104-132. DOI PMID
[4]	Bancroft T, Lim J, Wang C, et al. Health care resource utilization,costs,and persistence in patients newly diagnosed as having nonvalvular atrial fibrillation and newly treated with dabigatran versus warfarin in the United States[J]. Clin Ther, 2016, 38(3):545-556. DOI PMID
[5]	张澍, 杨艳敏, 黄从新, 等. 中国心房颤动患者卒中预防规范(2017)[J]. 中华心律失常学杂志, 2018, 22(1):17-30.
	Zhang S, Yang YM, Huang CX, et al. Guideline of stroke prevention in Chinese patients with atrial fibrillation(2017)[J]. Chin J Cardiac Arrhythm, 2018, 22(1):17-30.
[6]	Turakhia MP, Shafrin J, Bognar K, et al. Estimated prevalence of undiagnosed atrial fibrillation in the United States[J]. PLoS One, 2018, 13(4):e0195088. DOI URL
[7]	Lane DA, Meyerhoff J, Rohner U, et al. Atrial fibrillation patient preferences for oral anticoagulation and stroke knowledge:results of a conjoint analysis[J]. Clin Cardiol, 2018, 41(6):855-861. DOI URL
[8]	Ozaki AF, Choi AS, Le QT, et al. Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation:a systematic review and meta-analysis[J]. Circ Cardiovasc Qual Outcomes, 2020, 13(3):e005969. DOI URL
[9]	魏春岚, 王园园, 刘砚燕, 等. 移动医疗领域智能手机健康管理的研究进展[J]. 护理学报, 2014, 21(12):8-11.
	Wei CL, Wang YY, Liu YY, et al. Research progress of smartphone health management in mobile health field[J]. J Nurs, 2014, 21(12):8-11.
[10]	Lane DA, McMahon N, Gibson J, et al. Mobile health applications for managing atrial fibrillation for healthcare professionals and patients:a systematic review[J]. Europace, 2020:2020,269.
[11]	World Health Organization. mHealth:new horizons for health through mobile technologies[EB/OL]. (2011-06-07)[2021-08-22]. https://www.mobileworldlive.com/mhealth-new-horizons-for-health-through-mobile-technologies.
[12]	黄聪, 谌永毅, 刘翔宇, 等. 移动医疗在护理领域的应用进展[J]. 中华护理杂志, 2019, 54(8):1264-1269.
	Huang C, Chen YY, Liu XY, et al. Review of mobile health in nursing field[J]. Chin J Nurs, 2019, 54(8):1264-1269.
[13]	We Are Social, Hootsuite. Digital 2022:global overview report[EB/OL]. (2022-01-26)(2022-03-14). https://wearesocial.com/cn/blog/2022/01/digital-2022/.
[14]	Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J, 2016, 37(38):2893-2962. DOI PMID
[15]	Lopez Perales CR, van Spall HGC, Maeda S, et al. Mobile health applications for the detection of atrial fibrillation:a systematic review[J]. Europace, 2021, 23(1):11-28. DOI PMID
[16]	Yan BP, Lai WHS, Chan CKY, et al. Contact-free screening of atrial fibrillation by a smartphone using facial pulsatile photoplethysmographic signals[J]. J Am Heart Assoc, 2018, 7(8):e008585. DOI URL
[17]	Bansal A, Joshi R. Portable out-of-hospital electrocardiography:a review of current technologies[J]. J Arrhythm, 2018, 34(2):129-138. DOI PMID
[18]	Halcox JPJ, Wareham K, Cardew A, et al. Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation:the REHEARSE-AF study[J]. Circulation, 2017, 136(19):1784-1794. DOI URL
[19]	苏晞, 张劲林, 韩宏伟, 等. 单导联心电图记录系统进行心房颤动机会性筛查的首个国内经验[J]. 中华心律失常学杂志, 2017, 21(6):485-488.
	Su X, Zhang JL, Han HW, et al. Pioneering experience of single-lead electrocardiogram for opportunistic screening for atrial fibrillation in China[J]. Chin J Cardiac Arrhythm, 2017, 21(6):485-488.
[20]	Lahdenoja O, Hurnanen T, Iftikhar Z, et al. Atrial fibrillation detection via accelerometer and gyroscope of a smartphone[J]. IEEE J Biomed Health Inform, 2018, 22(1):108-118. DOI URL
[21]	Guo YT, Wang H, Zhang H, et al. Mobile photoplethysmographic technology to detect atrial fibrillation[J]. J Am Coll Cardiol, 2019, 74(19):2365-2375. DOI URL
[22]	Conroy T, Guzman JH, Hall B, et al. Detection of atrial fibrillation using an earlobe photoplethysmographic sensor[J]. Phy-siol Meas, 2017, 38(10):1906-1918.
[23]	Doliwa PS, Frykman V, Rosenqvist M. Short-term ECG for out of hospital detection of silent atrial fibrillation episodes[J]. Scand Cardiovasc J, 2009, 43(3):163-168. DOI URL
[24]	Rivezzi F, Vio R, Bilato C, et al. Screening of unknown atrial fibrillation through handheld device in the elderly[J]. J Geriatr Cardiol, 2020, 17(8):495-501.
[25]	Guo YT, Chen YD, Lane DA, et al. Mobile health technology for atrial fibrillation management integrating decision support,education,and patient involvement:mAF app trial[J]. Am J Med, 2017, 130(12):1388-1396.e6. DOI URL
[26]	Zeballos-Palacios CL, Hargraves IG, Noseworthy PA, et al. Developing a conversation aid to support shared decision making:reflections on designing anticoagulation choice[J]. Mayo Clin Proc, 2019, 94(4):686-696. DOI PMID
[27]	Kunneman M, Branda ME, Hargraves IG, et al. Assessment of shared decision-making for stroke prevention in patients with atrial fibrillation:a randomized clinical trial[J]. JAMA Intern Med, 2020, 180(9):1215-1224. DOI PMID
[28]	Turchioe MR, Jimenez V, Isaac S, et al. Review of mobile applications for the detection and management of atrial fibrillation[J]. Heart Rhythm O2, 2020, 1(1):35-43. DOI PMID
[29]	葛红玥, 林梅, 许志英. 心房颤动患者症状群及其影响因素研究[J]. 中华护理杂志, 2020, 55(8):1189-1196.
	Ge HY, Lin M, Xu ZY. Analysis of characteristics of patients with atrial fibrillation distributed by different symptom clusters[J]. Chin J Nurs, 2020, 55(8):1189-1196.
[30]	Hirschey J, Bane S, Mansour M, et al. Evaluating the usability and usefulness of a mobile app for atrial fibrillation using qualitative methods:exploratory pilot study[J]. JMIR Hum Factors, 2018, 5(1):e13. DOI URL
[31]	Ghanbari H, Ansari S, Ghannam M, et al. Feasibility and usability of a mobile application to assess symptoms and affect in patients with atrial fibrillation:a pilot study[J]. J Atr Fibrillation, 2017, 10(2):1672.
[32]	Jiang SD, He QY, Yan JJ, et al. Evaluation of a pharmacist-led remote warfarin management model using a smartphone application(Yixing) in improving patients’ knowledge and outcomes of anticoagulation therapy[J]. Front Pharmacol, 2021, 12:677943. DOI URL
[33]	杜宜修, 吴芳琴, 卢晓英, 等. 多学科团队延续性护理模式在心房颤动患者中的应用研究[J]. 中华护理杂志, 2020, 55(7):969-974.
	Du YX, Wu FQ, Lu XY, et al. The application effects of continuous nursing care in management of patients with atrial fibrillation by a nurse-led multidisciplinary team[J]. Chin J Nurs, 2020, 55(7):969-974.
[34]	Hsieh HL, Kao CW, Cheng SM, et al. A web-based integrated management program for improving medication adherence and quality of life,and reducing readmission in patients with atrial fibrillation:randomized controlled trial[J]. J Med Internet Res, 2021, 23(9):e30107. DOI URL
[35]	Stephan LS, Almeida ED, Guimarães RB, et al. Oral anticoagulation in atrial fibrillation:development and evaluation of a mobile health application to support shared decision-making[J]. Arq Bras Cardiol, 2018, 110(1):7-15. DOI PMID
[36]	Tawfik A, Bielecki JM, Krahn M, et al. Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation[J]. Clin Pharmacol, 2016, 8:93-107.
[37]	伍珊珊, 黄远平, 谢铄, 等. 非瓣膜病房颤患者口服新型抗凝药依从性的调查[J]. 中华护理杂志, 2019, 54(6):878-882.
	Wu SS, Huang YP, Xie S, et al. Adherence and associated factors of non-vitamin K antagonist oral anticoagulants therapy in patients with non-valvular atrial fibrillation[J]. Chin J Nurs, 2019, 54(6):878-882.
[38]	Desteghe L, Vijgen J, Koopman P, et al. Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation[J]. Eur Heart J, 2018, 39(16):1394-1403. DOI PMID
[39]	Turakhia M, Sundaram V, Smith SN, et al. Efficacy of a centralized,blended electronic,and human intervention to improve direct oral anticoagulant adherence:smartphones to improve rivaroxaban ADHEREnce in atrial fibrillation(smartADHERE) a randomized clinical trial[J]. Am Heart J, 2021, 237:68-78. DOI PMID
[40]	Cai C, Bao ZP, Wu N, et al. A novel model of home-based,patient-tailored and mobile application-guided cardiac telerehabilitation in patients with atrial fibrillation:a randomised controlled trial[J]. Clin Rehabil, 2022, 36(1):40-50. DOI URL
[41]	Goni L, Barrio-López MT, et al. A remote nutritional intervention to change the dietary habits of patients undergoing ablation of atrial fibrillation:randomized controlled trial[J]. J Med Internet Res, 2020, 22(12):e21436. DOI URL
[42]	Ayyaswami V, Padmanabhan DL, Crihalmeanu T, et al. Mobile health applications for atrial fibrillation:a readability and quality assessment[J]. Int J Cardiol, 2019, 293:288-293. DOI PMID
[43]	Pearsons A, Hanson CL, Gallagher R, et al. Atrial fibrillation self-management:a mobile telephone app scoping review and content analysis[J]. Eur J Cardiovasc Nurs, 2021, 20(4):305-314. DOI URL
[44]	O’Neill ES, Grande SW, Sherman A, et al. Availability of patient decision aids for stroke prevention in atrial fibrillation:a systematic review[J]. Am Heart J, 2017, 191:1-11. DOI URL
[45]	王苑蓉, 陈丽, 胡春艳. 老年患者移动医疗使用意愿及影响因素调查[J]. 护理学杂志, 2019, 34(7):73-76.
	Wang YR, Chen L, Hu CY. Willingness of elderly patients to use mobile medical services and its influencing factors[J]. J Nurs Sci, 2019, 34(7):73-76.
[46]	Verbrugge FH, Proesmans T, Vijgen J, et al. Atrial fibrillation screening with photo-plethysmography through a smartphone camera[J]. Europace, 2019, 21(8):1167-1175. DOI PMID
[47]	Ding EY, Marcus GM, McManus DD. Emerging technologies for identifying atrial fibrillation[J]. Circ Res, 2020, 127(1):128-142. DOI URL